ERBB2 and breast cancer: Hormone receptor-positive, human epidermal growth factor receptor 2 negative (HR-positive/HER2-negative) breast cancers, which have the most favorable outcomes, are 23% higher in White women over the age of 20 years old than Black women of the same age, and 45% higher than in Hispanic and American Indian/Alaska Native women of the same ages.